October 30, 2017
A New York grocery union benefits fund slapped Johnson & Johnson with a proposed class action Friday in Pennsylvania federal court, alleging the pharmaceutical giant abused its monopoly power to quash less expensive, generic versions of its best-selling Remicade drug, resulting in higher prices.